News of the WeekIntellectual Property

NIH Cuts Deal on Use of OncoMouse

See allHide authors and affiliations

Science  28 Jan 2000:
Vol. 287, Issue 5453, pp. 567
DOI: 10.1126/science.287.5453.567a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


A new agreement cuts away some red tape that has been a serious annoyance for cancer researchers. The policy, announced by the National Institutes of Health (NIH) on 19 January, allows NIH-funded scientists doing noncommercial research to use patented transgenic animals without obtaining specific approval of E. I. du Pont de Nemours and Co. of Wilmington, Delaware.